151 related articles for article (PubMed ID: 33708562)
1. Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma.
Lyu W; Fei X; Chen C; Tang Y
Gland Surg; 2021 Feb; 10(2):807-815. PubMed ID: 33708562
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Prognostic Model for Post-Operative Recurrence of Pituitary Adenomas.
Lu L; Wan X; Xu Y; Chen J; Shu K; Lei T
Front Oncol; 2022; 12():882049. PubMed ID: 35574399
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Related Factors of Tumor Recurrence or Progression After Transnasal Sphenoidal Surgical Treatment of Large and Giant Pituitary Adenomas and Establish a Nomogram to Predict Tumor Prognosis.
Chen Y; Cai F; Cao J; Gao F; Lv Y; Tang Y; Zhang A; Yan W; Wang Y; Hu X; Chen S; Dong X; Zhang J; Wu Q
Front Endocrinol (Lausanne); 2021; 12():793337. PubMed ID: 34970226
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors.
Bernat AL; Troude P; Priola SM; Elsawy A; Farrash F; Mete O; Ezzat S; Asa SL; De Almeida J; Vescan A; Monteiro E; Almeida JP; Zadeh GM; Gentili F
World Neurosurg; 2021 Feb; 146():e341-e350. PubMed ID: 33203535
[TBL] [Abstract][Full Text] [Related]
5. Sphenoid sinus mucosal thickening in patients with non-functioning pituitary adenoma.
Şahin B; Topaloğlu Ö
Int J Clin Pract; 2021 Oct; 75(10):e14604. PubMed ID: 34228864
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System.
Hwang J; Seol HJ; Nam DH; Lee JI; Lee MH; Kong DS
Brain Tumor Res Treat; 2016 Oct; 4(2):63-69. PubMed ID: 27867914
[TBL] [Abstract][Full Text] [Related]
7. Preoperative prediction of cavernous sinus invasion by pituitary adenomas using a radiomics method based on magnetic resonance images.
Niu J; Zhang S; Ma S; Diao J; Zhou W; Tian J; Zang Y; Jia W
Eur Radiol; 2019 Mar; 29(3):1625-1634. PubMed ID: 30255254
[TBL] [Abstract][Full Text] [Related]
8. High-Field Intraoperative Magnetic Resonance Imaging Increases Extent of Resection and Progression-Free Survival for Nonfunctioning Pituitary Adenomas.
Zhang Z; Yang K; Xia Y; Meng X; Yu X
World Neurosurg; 2019 Jul; 127():e925-e931. PubMed ID: 30974275
[TBL] [Abstract][Full Text] [Related]
9. MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas.
Machado LF; Elias PCL; Moreira AC; Dos Santos AC; Murta Junior LO
Comput Biol Med; 2020 Sep; 124():103966. PubMed ID: 32860977
[TBL] [Abstract][Full Text] [Related]
10. Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence.
Guo J; Fang Q; Liu Y; Xie W; Zhang Y; Li C
Oncol Lett; 2021 Apr; 21(4):264. PubMed ID: 33664827
[TBL] [Abstract][Full Text] [Related]
11. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
12. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas.
Chang EF; Zada G; Kim S; Lamborn KR; Quinones-Hinojosa A; Tyrrell JB; Wilson CB; Kunwar S
J Neurosurg; 2008 Apr; 108(4):736-45. PubMed ID: 18377253
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and risk factors for headache associated with non-functioning pituitary adenomas.
Yu B; Ji N; Ma Y; Yang B; Kang P; Luo F
Cephalalgia; 2017 Apr; 37(4):348-355. PubMed ID: 27154998
[TBL] [Abstract][Full Text] [Related]
14. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
15. Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma.
Lee MH; Lee JH; Seol HJ; Lee JI; Kim JH; Kong DS; Nam DH
Brain Tumor Res Treat; 2016 Apr; 4(1):1-7. PubMed ID: 27195254
[TBL] [Abstract][Full Text] [Related]
16. Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre- and post-surgical endocrine and visual function.
Subramanian V; Lee RSM; Howell S; Gregson S; Lahart IM; Kaushal K; Pappachan JM
Endocrine; 2021 Aug; 73(2):407-415. PubMed ID: 33822319
[TBL] [Abstract][Full Text] [Related]
17. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
[TBL] [Abstract][Full Text] [Related]
19. The natural history of non-functioning pituitary adenomas: A meta-analysis of conservatively managed tumors.
Pernik MN; Montgomery EY; Isa S; Sundarrajan C; Caruso JP; Traylor JI; Liu Y; Garzon-Muvdi T
J Clin Neurosci; 2022 Jan; 95():134-141. PubMed ID: 34929637
[TBL] [Abstract][Full Text] [Related]
20. Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.
Cheng S; Wu J; Li C; Li Y; Liu C; Li G; Li W; Hu S; Ying X; Zhang Y
J Transl Med; 2019 May; 17(1):164. PubMed ID: 31109334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
